The Latest Cardiac and Vascular News
Industry-leading platform combines clinical excellence and workflow innovation, helping clinicians and hospitals to deliver outstanding patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the one millionth procedure on its flagship Azurion image-guided therapy platform. Since its introduction in February 2017, Azurion […]
December 2, 2019 Leading health system leverages Philips diagnostic imaging and patient monitoring solutions to deliver on Quadruple Aim: better outcomes, increased efficiency, and improved patient and staff experience Andover, U.S. and Mullica Hill, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Inspira Health (Inspira), today […]
November 27, 2019 Industry-leading platform combines clinical excellence and workflow innovation, helping clinicians and hospitals to deliver outstanding patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the one millionth procedure on its flagship Azurion image-guided therapy platform. Since its introduction […]
Stellarex’s unique coating enables a low therapeutic drug dose and has demonstrated a significant treatment effect and high safety profile Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced two new balloons to its Stellarex 0.035” low-dose drug-coated balloon (DCB) portfolio. The new 200mm […]
Primary safety analysis of Stellarex drug-coated balloon (DCB) three-year data, comprising the largest published, pooled set of randomized controlled trial (RCT) data for a single paclitaxel-based device, shows no difference in mortality between patients treated with the Philips Stellarex DCB and those treated with percutaneous angioplasty, the current standard of […]
LindaCare’s OnePulse combines with Philips’ IntelliSpace Cardiovascular informatics platform to streamline in-hospital and remote follow-up care for patients with cardiac implantable electronic devices LEUVEN, Belgium and STAMFORD, Conn., Aug. 29, 2019 /PRNewswire/ — Prior to the European Society of Cardiology (ESC) Congress 2019 (Paris, France, August 31 – September 4), LindaCare announced that it is collaborating with Philips to combine LindaCare’s innovative […]
Enhanced communication and seamless data sharing capabilities augment clinical and operational efficiencies for patient assessment across emergency care settings Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the HeartStart Intrepid monitor/defibrillator with IntelliSpace Connect. Created to provide clinical and operational […]
Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its response to the U.S. Food and Drug Administration’s (FDA) Letter to Health Care Providers regarding treatment of peripheral artery disease (PAD) in the superficial femoropopliteal artery (SFA) with paclitaxel-coated devices. Importantly, the FDA recommendation continues […]
Philips delivers Q2 sales of EUR 4.7 billion, with 6% comparable sales growth and 8% comparable order intake growth; income from continuing operations increases to EUR 260 million and Adjusted EBITA margin improves to 11.8% Second-quarter highlights Sales in the quarter amounted to EUR 4.7 billion, with 6% comparable sales […]
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced shipment of its two-millionth AED (Automated External Defibrillator), which was delivered to a customer in Italy. This achievement marks a major milestone in almost 20 years of Philips innovation in cardiac resuscitation aimed at […]
